Works matching IS 19466234 AND DT 2020 AND VI 12 AND IP 531
Results: 3
BRCAness, SLFN11, and RB1 loss predict response to topoisomerase I inhibitors in triple-negative breast cancers.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 531, p. 1, doi. 10.1126/scitranslmed.aax2625
- By:
- Publication type:
- Article
Anti--PD-1 treatment impairs opioid antinociception in rodents and nonhuman primates.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 531, p. 1, doi. 10.1126/scitranslmed.aaw6471
- By:
- Publication type:
- Article
Long noncoding RNA SNHG12 integrates a DNA-PK--mediated DNA damage response and vascular senescence.
- Published in:
- Science Translational Medicine, 2020, v. 12, n. 531, p. 1, doi. 10.1126/scitranslmed.aaw1868
- By:
- Publication type:
- Article